Table 3.

Cox regression for disease-free survival.

	Univariate			Multivariate
Variable	HR	95% CI	p	HR	95% CI	p
TP53 mutated vs. not mutated	6.50	2.39–17.68	0.0002	4.34	1.11–16.99	0.03
WT1 mutated vs. not mutated	3.06	1.01–8.93	0.04	5.97	1.70–20.99	0.005
NRAS mutated vs. not mutated	2.75	0.94–8.03	0.06	4.78	1.34–17.02	0.01
Cytogenetic risk adverse vs. others	3.55	1.47–8.55	0.005	3.03	1.12–9.02	0.04
FLT3 mutated vs. not mutated	2.05	0.89–4.72	0.09	3.36	1.19–9.54	0.02
ELN risk adverse vs. others	2.19	1.01–4.76	0.04	1.95	0.77–4.96	0.1
Donor age continuous	0.96	0.93–0.99	0.006	0.97	0.93–0.99	0.04
Complete remission at SCT yes vs. no	0.34	0.16–0.74	0.007	0.23	0.09–0.56	0.001